LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

MP142A PHASE 2/3 STUDY OF THE EFFICACY AND SAFETY OF BARDOXOLONE METHYL IN PATIENTS WITH ALPORT SYNDROME

Photo by impulsq from unsplash

Presented at the European Renal Association – European Dialysis and Transplant Association June 5, 2017; Madrid, Spain 1. Yoh K et al. Kidney Int. 2001, 60(4):1343-53 2. Ma Q et… Click to show full abstract

Presented at the European Renal Association – European Dialysis and Transplant Association June 5, 2017; Madrid, Spain 1. Yoh K et al. Kidney Int. 2001, 60(4):1343-53 2. Ma Q et al. Am J. Pathol. 2006, 168(6):1960-74 3. Sporn MB et al. J Nat Prod. 2011, 74(3):537-45 4. Ruiz S et al. Kidney Int. 2013, 83(6):1029-41 5. Zoja et al. Am J Phy Renal Phy. 2010, 299(5):F1203-11 6. Aminzadeh MA et al. Nephrol Dial Transplant. 2013, 28(8):2038-45 7. Ding et al. Kidney Int. 2013, 83(5):845-54 8. Pergola et al. Am J Nephrol. 2011, 33(5):469-76 9. http://www.kyowa-kirin.com/news_releases/2016/pdf/e20160523_01.pdf 10. Pergola et al. N Engl J Med. 2011, 365(4):327-36 Screen Dose-Titration Period

Keywords: efficacy safety; safety bardoxolone; study efficacy; mp142a phase; kidney int; phase study

Journal Title: Nephrology Dialysis Transplantation
Year Published: 2017

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.